Business Development Manager at Wildcat Discovery Technologies
Location:
Greater San Diego Area
Industry:
Chemicals
Work:
Wildcat Discovery Technologies since Mar 2009
Business Development Manager
Wildcat Discovery Technologies Nov 2006 - Mar 2009
Manager of Operations
Genomics Institute of the Novartis Research Foundation 2002 - 2006
Scientific Associate
Education:
The University of Chicago - Booth School of Business 2011 - 2013
Master of Business Administration (M.B.A.), Finance, Operations, Strategic Management
University of California, San Diego 2003 - 2004
Masters of Science, Chemistry
University of California, San Diego 1997 - 2001
Bachelors of Arts, Economics
University of California, San Diego 1997 - 2001
Bachelors of Science, Biochemistry
Us Patents
Compounds And Methods For Modulating G Protein-Coupled Receptors
Robert Epple - San Diego CA, US Mihai Azimioara - San Diego CA, US Christopher Cow - San Diego CA, US Ross Russo - Encinitas CA, US Victor Nikulin - San Diego CA, US Gerald Lelais - San Diego CA, US
Assignee:
IRM LLC - Hamilton
International Classification:
A61K 31/426 A61K 31/421 C07D 277/20 C07D 263/30
US Classification:
514365, 435375, 514374, 548202, 548235
Abstract:
The invention provides compounds and pharmaceutical compositions thereof, which are useful for modulating G protein-coupled receptor 120 (GPR120), and methods for using such compounds to treat, ameliorate or prevent a condition associated with abnormal or deregulated GPR120.
Robert Epple - San Diego CA, US Christopher Cow - San Diego CA, US Yongping Xie - San Diego CA, US Xing Wang - San Diego CA, US Ross Russo - San Diego CA, US Mihai Azimioara - La Jolla CA, US Enrique Saez - San Diego CA, US
The invention provides compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of the Peroxisome Proliferator-Activated Receptor (PPAR) families, particularly the activity of PPAR.
Robert Epple - San Diego CA, US Yongping Xie - San Diego CA, US Xing Wang - San Diego CA, US Christopher Cow - San Diego CA, US Ross Russo - Encinitas CA, US
The invention provides compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of the Peroxisome Proliferator-Activated Receptor (PPAR) families, particularly the activity of PPAR.
Robert Epple - San Diego CA, US Ross Russo - Encinitas CA, US Mihai Azimioara - La Jolla CA, US Yongping Xie - San Diego CA, US
International Classification:
A61K 31/42 C07D 261/06 A61P 3/10 A61P 9/00
US Classification:
514380, 548243
Abstract:
The invention provides compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of the Peroxisome Proliferator-Activated Receptor (PPAR) families, particularly the activity of PPAR.
Robert Epple - San Diego CA, US Yongping Xie - San Diego CA, US Xing Wang - San Diego CA, US Ross Russo - Encinitas CA, US Christopher Cow - San Diego CA, US Mihai Azimioara - La Jolla CA, US
The invention provides compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of the Peroxisome Proliferator-Activated Receptor (PPAR) families.
The invention provides compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of the Peroxisome Proliferator-Activated Receptor (PPAR) families.
Robert Epple - San Diego CA, US Ross Russo - Encinitas CA, US Mihai Azimioara - La Jolla CA, US Christopher Cow - San Diego CA, US Valentina Molteni - San Diego CA, US Xiaolin Li - San Diego CA, US Donatella Chianelli - San Diego CA, US
Robert Epple - San Diego CA, US Christopher Cow - San Diego CA, US Mihai Azimioara - La Jolla CA, US Ross Russo - Encinitas CA, US Yongping Xie - San Diego CA, US Xing Wang - San Diego CA, US
The invention provides compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of the Peroxisome Proliferator-Activated Receptor (PPAR) families.
Flickr
Youtube
Garmin NXi Upgrade for the Embraer Phenom 100...
This is part 2 of our series with Ross Russo. One of our favorite proj...
Duration:
2m 16s
Jim Ross shoots on Vince Russo's booking
For over forty years Jim Ross has been the Voice of Wrestling. From st...
Duration:
10m 3s
Bruce Prichard shoots on Vince Russo's heat w...
Something to Wrestle with Bruce Prichard is an audio podcast that disc...
Duration:
9m 41s
Garmin NXi Upgrade for the Embraer Phenom 100...
One of our favorite projects has been the Garmin NXi Avionics Suite up...
Duration:
11m 43s
Jim Ross shoots on Vince Russo wanting more m...
For over forty years Jim Ross has been the Voice of Wrestling. From st...
Duration:
3m 54s
The Ross Report #30 | Vince Russo
This episode was made by PodcastOne, hosted by Jim Ross and produced b...